Conference item : Abstract
Selective inhibition of Janus kinase 1 (JAK1) by filgotinib modulates the disease-associated whole blood transcriptional profile of patients with active rheumatoid arthritis
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 92.2KB, Terms of use)
-
- Publisher copy:
- 10.1136/annrheumdis-2019-eular.2509
Authors
- Publisher:
- BMJ Publishing Group
- Host title:
- Annals of Rheumatic Diseases
- Journal:
- European Congress of Rheumatology Annual meeting - EULAR 2019 More from this journal
- Volume:
- 78
- Issue:
- S2
- Pages:
- 374-375
- Publication date:
- 2019-05-27
- Acceptance date:
- 2019-03-29
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- Subtype:
-
Abstract
- Pubs id:
-
pubs:987873
- UUID:
-
uuid:c58c600d-d140-40a7-abb6-ef859232676f
- Local pid:
-
pubs:987873
- Source identifiers:
-
987873
- Deposit date:
-
2019-04-11
- ARK identifier:
Terms of use
- Copyright holder:
- Taylor et al
- Copyright date:
- 2019
- Notes:
- This abstract was presented at the European Congress of Rheumatology Annual meeting - EULAR 2019, 12-15 June 2019, Madrid, Spain.
If you are the owner of this record, you can report an update to it here: Report update to this record